National Commission on AIDS: Annual Report to the President and Congress

NATIONAL COMMISSION ON AIDS

AGENDA
MAY 7-8, 1990
Pan American Health Organization Building
525 23rd Street N.W.
Meeting Room B
Washington, D.C.
Monday. May 7, 1990
8:00 a.m. NATIONAL ACADEMY OF SCIENCES OVERVIEW
Samuel O. Thier, M.D., President, Institute of Medicine
Robin Weiss, M.D, Director, AIDS Activities, Institute of Medicine
Charles Turner, Ph.D, Director, Committee on AIDS Research and the
Behavioral, Social, and Statistical Sciences, National Research Council
9:00 a.m. DRUG DEVELOPMENT AND APPROVAL OVERVIEW
Ellen C. Cooper, M.D., M.P.H., Director, Division of Antiviral Drug Products,
Food and Drug Administration
Gerald Quinnan, M.D., Deputy Director, Center for Biologics Evaluation and
Research, Food and Drug Administration
Joel Solomon, Ph.D., Director, Division of Blood and Blood Products, Center
for Biologics Evaluation and Research, Food and Drug Administration
John C. Petricciani, M.D., Vice President, Medical and Regulatory Affairs,
Pharmaceutical Manufacturers Association
9:45 a.m. BREAK
10:15 a.m. NATIONAL INSTITUTES OF HEALTH OVERVIEW
Anthony S. Fauci, M.D., Director, Office of AIDS Research, National
Institutes of Health
Philip A. Pizzo, M.D., Chief of Pediatrics, Head, Infectious Disease Section,
National Cancer Institute
Janet Heinrick, Dr.P.H., R.N., Director, Division of Extramural Programs,
National Center for Nursing Research
11:30 a.m. COMMUNITY NEEDS AND PERSPECTIVES
Sonia Singleton, Community Outreach Education and Prevention Inc., Miami,
Florida
Jim Eigo, M.F.A., ACT UP

117